Oxidized fish oils increased lipid deposition via oxidative stress-mediated mitochondrial dysfunction and the CREB1-Bcl2-Beclin1 pathway in the liver tissues and hepatocytes of yellow catfish
At current, the dangerous results and related mechanism of oxidized fish oils on fish and fish cells stay unknown. Our examine discovered that oxidized fish oils elevated lipogenesis, and diminished lipolysis, activated oxidative stress by reducing glutathione peroxidase (GPX) exercise, rising malondialdhyde (MDA) content material and damaging mitochondrial construction, and activated autophagy within the liver of yellow catfish; oxidized eicosapentaenoic acid (oxEPA) induced oxidative stress in yellow catfish hepatocytes. Oxidative stress, mitochondrial dysfunction and lipophagy mediated oxEPA induced-variations in lipid metabolism. Our additional investigation indicated that oxEPA-activated lipophagy was through inhibiting the DNA binding capability of the cAMP-response factor binding protein (CREB)-1 to the area of Bcl-2 promoter, which in flip suppressed the binding exercise of Bcl-2 to Beclin1 and promoted autophagosome formation. For the primary time, our examine elucidated the mechanisms of oxidized fish oils-induced lipid deposition by the oxidative stress, mitochondrial dysfunction and CREB1-Bcl-2-Beclin1 pathway in fish.
Acute toxicity evaluation of an inhibitor of BCL2, Disarib, in rats
Apoptosis or programmed cell loss of life is a extremely regulated course of, which eliminates undesirable and broken cells. Inhibition of apoptosis is a trademark of most cancers cells. BCL2 household proteins are recognized to play an important function within the regulation of apoptosis. Overexpression of BCL2, an antiapoptotic protein, offers the benefit of extended survival to most cancers cells. Over time, a number of BCL2 inhibitors have been investigated extensively for his or her anticancer potential. Nevertheless, most of them have been abolished earlier than scientific use because of their negative effects. Beforehand, we had recognized and characterised a novel BCL2 inhibitor, Disarib, with the potential to remove tumor cells in a BCL2 particular method resulting in discount in tumor burden in a number of mouse fashions.
Notably, a head-to-head comparability of Disarib to ABT199, the one FDA authorised BCL2 inhibitor revealed that Disarib is as potent as ABT199. Current research utilizing mice revealed that Disarib didn’t invoke important negative effects in mice. Within the current examine, we now have investigated the acute toxicity of Disarib in Wistar rats. The bioavailability research following publicity of Disarib in Wistar rats revealed its most availability in serum at 24 h following oral administration. Acute toxicity evaluation revealed that even a dose as excessive as 2000 mg/kg of Disarib didn’t trigger important toxicity in rats.
There was no important variation in blood parameters or kidney and liver capabilities following administration of Disarib. Histological evaluation of various tissues from Disarib handled teams revealed normal structure with no observable mobile injury. Importantly, publicity to Diasrib didn’t lead to genotoxicity as decided by micronucleus assay. Additional, solubility assays revealed that moreover DMSO, Disarib can also be soluble in alcohol. Whereas the excessive acidic situation can improve the solubility of Disarib, even a decrease proportion of alcohol with acidic situations can enhance its solubility. Thus, the toxicological profile within the present examine revealed no important negative effects when Disarib was administered orally to rats.
A brand new pathological classification of intrahepatic cholangiocarcinoma in keeping with protein expression of SSTR2 and Bcl2
Background: No common classification methodology for intrahepatic cholangiocarcinoma (IHCC) has been reported primarily based on the embryological origin of biliary epithelial cells. The intention of this examine was to categorise IHCC in keeping with protein expression ranges of somatostatin receptor 2 (SSTR2) and b-cell leukemia/lymphoma 2 (Bcl2) and to elucidate the clinicopathological options of every group.
Strategies: Fifty-two IHCC sufferers who underwent hepatic resection have been enrolled on this examine. Protein expression ranges of SSTR2 and Bcl2 have been examined utilizing immunohistochemistry. Clinicopathological elements have been in contrast between the three teams and prognostic elements have been investigated.
Outcomes: The sufferers have been divided into three teams: SSTR2 constructive and Bcl2 adverse (p-Group H, n = 21), SSTR2 adverse and Bcl2 constructive (p-Group P, n = 14), and the indeterminate group (p-Group U, n = 17) for circumstances the place SSTR2 and Bcl2 have been each constructive or each adverse. All p-Group P circumstances displayed curability A or B. The 5-year survival charges of p-Group H and U sufferers have been worse than these in p-Group P. p-Group H had greater T-factor, scientific stage, and incidence of periductal infiltration than p-Group P.
Conclusions: This methodology may very well be used to categorise IHCC into peripheral and perihilar kind by embryological expression patterns of SSTR2 and Bcl2.
Key phrases: Bcl2; Clinicopathological traits; Immunohistochemistry; Prognosis; SSTR2.
Down regulation of lactate dehydrogenase initiates apoptosis in HeLa and MCF-7 most cancers cells by way of elevated voltage-dependent anion channel protein and inhibition of BCL2
Malignant cells generally use cardio glycolysis for ATP manufacturing; this is called the Warburg impact, the place pyruvate is transformed to lactate, by enzyme lactate dehydrogenase A (LDH-A). On this examine, we now have investigated the impact of inhibition of LDH-A on cells viability and figuring out the mechanism of cell loss of life in HeLa and MCF-7 most cancers cells. Human cervical most cancers HeLa cell line and breast most cancers MCF-7 cell line have been used to research the impact of inhibition of LDH-A by sodium oxamate on cell survival and proliferation utilizing western blot, spectrophotometry, and immunofluorescent examine.
There was important discount in LDH-A (P < 0.001) and cell viability (P < 0.001) in a dose-dependent mode in each HeLa and MCF-7 SO-treated most cancers cells. The voltage-dependent anion channel (VDAC) protein was considerably elevated (P < 0.001) in affiliation with decreased LDH-A. The proapoptotic proteins; cytochrome C (P < 0.001), BAX (P < 0.001), cleaved caspase-3 (P < 0.001), cleaved caspase-8 (P < 0.001), and cleaved caspase-9 (P < 0.001) have been considerably elevated in affiliation with decreased LDH-A. Whereas, the anti-apoptotic protein Bcl2 was considerably decreased (P < 0.001) in affiliation with decreased LDH-A. We conclude that Inhibition of LDH-A can lower cells viability by way of activation of intrinsic apoptotic pathway through elevated VDAC protein and inhibition of Bcl2 in addition to activation of the extrinsic apoptotic pathway by way of activation of caspase-8.
) Recombinant Escherichia coli col Protein (aa 1-205) |
|||
| VAng-Lsx02224-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3013.2 |
|
Description: Escherichia coli Colicin-E8, recombinant protein. |
|||
Recombinant Escherichia coli col Protein (aa 1-205) |
|||
| VAng-Lsx02224-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2040 |
|
Description: Escherichia coli Colicin-E8, recombinant protein. |
|||
) Recombinant Escherichia coli col Protein (aa 1-581) |
|||
| VAng-Lsx02225-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 7054.8 |
|
Description: Escherichia coli Colicin-E2, recombinant protein. |
|||
Recombinant Escherichia coli col Protein (aa 1-581) |
|||
| VAng-Lsx02225-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 4976.4 |
|
Description: Escherichia coli Colicin-E2, recombinant protein. |
|||
Recombinant Escherichia coli col Protein (aa 1-581) |
|||
| VAng-Lsx02225-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 3360 |
|
Description: Escherichia coli Colicin-E2, recombinant protein. |
|||
) Recombinant Escherichia coli col Protein (aa 1-582) |
|||
| VAng-Lsx02226-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 7071.6 |
|
Description: Escherichia coli Colicin-E9, recombinant protein. |
|||
Recombinant Escherichia coli col Protein (aa 1-582) |
|||
| VAng-Lsx02226-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 4992 |
|
Description: Escherichia coli Colicin-E9, recombinant protein. |
|||
Recombinant Escherichia coli col Protein (aa 1-582) |
|||
| VAng-Lsx02226-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 3376.8 |
|
Description: Escherichia coli Colicin-E9, recombinant protein. |
|||
) Recombinant Escherichia coli add Protein (aa 1-333) |
|||
| VAng-Lsx02151-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3952.8 |
|
Description: Escherichia coli (strain K12) Adenosine deaminase, recombinant protein. |
|||
Recombinant Escherichia coli add Protein (aa 1-333) |
|||
| VAng-Lsx02151-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2535.6 |
|
Description: Escherichia coli (strain K12) Adenosine deaminase, recombinant protein. |
|||
Recombinant Escherichia coli add Protein (aa 1-333) |
|||
| VAng-Lsx02151-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 687.6 |
|
Description: Escherichia coli (strain K12) Adenosine deaminase, recombinant protein. |
|||
) Recombinant Escherichia coli aer Protein (aa 1-506) |
|||
| VAng-Lsx02153-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli (strain K12) Aerotaxis receptor, recombinant protein. |
|||
) Recombinant Escherichia coli caa Protein (aa 1-204) |
|||
| VAng-Lsx02183-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli Colicin-A, recombinant protein. |
|||
) Recombinant Escherichia coli cba Protein (aa 2-321) |
|||
| VAng-Lsx02185-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5074.8 |
|
Description: Escherichia coli Colicin-B (aa 2-321), recombinant protein. |
|||
Recombinant Escherichia coli cba Protein (aa 2-321) |
|||
| VAng-Lsx02185-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3591.6 |
|
Description: Escherichia coli Colicin-B (aa 2-321), recombinant protein. |
|||
Recombinant Escherichia coli cba Protein (aa 2-321) |
|||
| VAng-Lsx02185-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2452.8 |
|
Description: Escherichia coli Colicin-B (aa 2-321), recombinant protein. |
|||
) Recombinant Escherichia coli cba Protein (aa 2-511) |
|||
| VAng-Lsx02186-100g | Creative Biolabs | 100 µg | EUR 8540.4 |
|
Description: Escherichia coli Colicin-B, recombinant protein. |
|||
Recombinant Escherichia coli cba Protein (aa 2-511) |
|||
| VAng-Lsx02186-50g | Creative Biolabs | 50 µg | EUR 5536.8 |
|
Description: Escherichia coli Colicin-B, recombinant protein. |
|||
) Recombinant Escherichia coli cbi Protein (aa 1-175) |
|||
| VAng-Lsx02187-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli Colicin-B immunity protein, recombinant protein. |
|||
) Recombinant Escherichia coli cda Protein (aa 1-697) |
|||
| VAng-Lsx02196-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 7946.4 |
|
Description: Escherichia coli Colicin-D, recombinant protein. |
|||
Recombinant Escherichia coli cda Protein (aa 1-697) |
|||
| VAng-Lsx02196-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 5602.8 |
|
Description: Escherichia coli Colicin-D, recombinant protein. |
|||
Recombinant Escherichia coli cda Protein (aa 1-697) |
|||
| VAng-Lsx02196-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 3771.6 |
|
Description: Escherichia coli Colicin-D, recombinant protein. |
|||
) Recombinant Escherichia coli cea Protein (aa 1-304) |
|||
| VAng-Lsx02198-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5751.6 |
|
Description: Escherichia coli Colicin-E1, recombinant protein. |
|||
Recombinant Escherichia coli cea Protein (aa 1-304) |
|||
| VAng-Lsx02198-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3657.6 |
|
Description: Escherichia coli Colicin-E1, recombinant protein. |
|||
Recombinant Escherichia coli cea Protein (aa 1-304) |
|||
| VAng-Lsx02198-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1083.6 |
|
Description: Escherichia coli Colicin-E1, recombinant protein. |
|||
) Recombinant Escherichia coli cfa Protein (aa 1-490) |
|||
| VAng-Lsx02200-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli Colicin-5, recombinant protein. |
|||
) Recombinant Escherichia coli cia Protein (aa 1-626) |
|||
| VAng-Lsx02201-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 7814.4 |
|
Description: Escherichia coli Colicin-Ia, recombinant protein. |
|||
Recombinant Escherichia coli cia Protein (aa 1-626) |
|||
| VAng-Lsx02201-1mgYeast | Creative Biolabs | 1 mg (Yeast) | EUR 9332.4 |
|
Description: Escherichia coli Colicin-Ia, recombinant protein. |
|||
) Recombinant Escherichia coli cib Protein (aa 1-626) |
|||
| VAng-Lsx02202-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli Colicin-Ib, recombinant protein. |
|||
) Recombinant Escherichia coli cib Protein (aa 280-355) |
|||
| VAng-Lsx02203-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3244.8 |
|
Description: Escherichia coli Protein Colicin-Ib, recombinant protein. |
|||
Recombinant Escherichia coli cib Protein (aa 280-355) |
|||
| VAng-Lsx02203-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2320.8 |
|
Description: Escherichia coli Protein Colicin-Ib, recombinant protein. |
|||
Recombinant Escherichia coli cib Protein (aa 280-355) |
|||
| VAng-Lsx02203-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1594.8 |
|
Description: Escherichia coli Protein Colicin-Ib, recombinant protein. |
|||
) Recombinant Escherichia coli cka Protein (aa 1-548) |
|||
| VAng-Lsx02204-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli Colicin-K, recombinant protein. |
|||
) Recombinant Escherichia coli cma Protein (aa 1-271) |
|||
| VAng-Lsx02208-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4712.4 |
|
Description: Escherichia coli Colicin-M, recombinant protein. |
|||
Recombinant Escherichia coli cma Protein (aa 1-271) |
|||
| VAng-Lsx02208-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3342 |
|
Description: Escherichia coli Colicin-M, recombinant protein. |
|||
Recombinant Escherichia coli cma Protein (aa 1-271) |
|||
| VAng-Lsx02208-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2287.2 |
|
Description: Escherichia coli Colicin-M, recombinant protein. |
|||
) Recombinant Escherichia coli cmi Protein (aa 1-141) |
|||
| VAng-Lsx02209-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3723.6 |
|
Description: Escherichia coli Colicin-M immunity protein, recombinant protein. |
|||
Recombinant Escherichia coli cmi Protein (aa 1-141) |
|||
| VAng-Lsx02209-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2667.6 |
|
Description: Escherichia coli Colicin-M immunity protein, recombinant protein. |
|||
Recombinant Escherichia coli cmi Protein (aa 1-141) |
|||
| VAng-Lsx02209-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1842 |
|
Description: Escherichia coli Colicin-M immunity protein, recombinant protein. |
|||
) Recombinant Escherichia coli cmk Protein (aa 1-227) |
|||
| VAng-Lsx02210-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3952.8 |
|
Description: Escherichia coli Cytidylate kinase, recombinant protein. |
|||
Recombinant Escherichia coli cmk Protein (aa 1-227) |
|||
| VAng-Lsx02210-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2535.6 |
|
Description: Escherichia coli Cytidylate kinase, recombinant protein. |
|||
Recombinant Escherichia coli cmk Protein (aa 1-227) |
|||
| VAng-Lsx02210-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 687.6 |
|
Description: Escherichia coli Cytidylate kinase, recombinant protein. |
|||
) Recombinant Escherichia coli cna Protein (aa 1-116) |
|||
| VAng-Lsx02211-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3525.6 |
|
Description: Escherichia coli Colicin-N, recombinant protein. |
|||
Recombinant Escherichia coli cna Protein (aa 1-116) |
|||
| VAng-Lsx02211-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2535.6 |
|
Description: Escherichia coli Colicin-N, recombinant protein. |
|||
Recombinant Escherichia coli cna Protein (aa 1-116) |
|||
| VAng-Lsx02211-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1743.6 |
|
Description: Escherichia coli Colicin-N, recombinant protein. |
|||
) Recombinant Escherichia coli cni Protein (aa 1-131) |
|||
| VAng-Lsx02212-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli Colicin-N immunity protein, recombinant protein. |
|||
) Recombinant Escherichia coli cnl Protein (aa 18-52) |
|||
| VAng-Lsx02213-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2931.6 |
|
Description: Escherichia coli Lysis protein for colicin N, recombinant protein. |
|||
Recombinant Escherichia coli cnl Protein (aa 18-52) |
|||
| VAng-Lsx02213-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2089.2 |
|
Description: Escherichia coli Lysis protein for colicin N, recombinant protein. |
|||
Recombinant Escherichia coli cnl Protein (aa 18-52) |
|||
| VAng-Lsx02213-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1462.8 |
|
Description: Escherichia coli Lysis protein for colicin N, recombinant protein. |
|||
) Recombinant Escherichia coli cta Protein (aa 1-490) |
|||
| VAng-Lsx02255-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli Colicin-10, recombinant protein. |
|||
) Recombinant Escherichia coli dcm Protein (aa 1-472) |
|||
| VAng-Lsx02337-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3079.2 |
|
Description: Escherichia coli (strain K12) DNA-cytosine methyltransferase, recombinant protein. |
|||
) Recombinant Escherichia coli def Protein (aa 2-169) |
|||
| VAng-Lsx02342-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3921.6 |
|
Description: Escherichia coli Peptide deformylase, recombinant protein. |
|||
Recombinant Escherichia coli def Protein (aa 2-169) |
|||
| VAng-Lsx02342-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2815.2 |
|
Description: Escherichia coli Peptide deformylase, recombinant protein. |
|||
Recombinant Escherichia coli def Protein (aa 2-169) |
|||
| VAng-Lsx02342-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1924.8 |
|
Description: Escherichia coli Peptide deformylase, recombinant protein. |
|||
) Recombinant Escherichia coli efp Protein (aa 2-188) |
|||
| VAng-Lsx02360-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4414.8 |
|
Description: Escherichia coli (strain K12) Elongation factor P, recombinant protein. |
|||
Recombinant Escherichia coli efp Protein (aa 2-188) |
|||
| VAng-Lsx02360-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2848.8 |
|
Description: Escherichia coli (strain K12) Elongation factor P, recombinant protein. |
|||
Recombinant Escherichia coli efp Protein (aa 2-188) |
|||
| VAng-Lsx02360-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 736.8 |
|
Description: Escherichia coli (strain K12) Elongation factor P, recombinant protein. |
|||
) Recombinant Escherichia coli etk Protein (aa 1-726) |
|||
| VAng-Lsx02367-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli (strain K12) Tyrosine-protein kinase etk, recombinant protein. |
|||
) Recombinant Escherichia coli fur Protein (aa 2-148) |
|||
| VAng-Lsx02396-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3952.8 |
|
Description: Escherichia coli (strain K12) Ferric uptake regulation protein, recombinant protein. |
|||
Recombinant Escherichia coli fur Protein (aa 2-148) |
|||
| VAng-Lsx02396-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2535.6 |
|
Description: Escherichia coli (strain K12) Ferric uptake regulation protein, recombinant protein. |
|||
Recombinant Escherichia coli fur Protein (aa 2-148) |
|||
| VAng-Lsx02396-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 687.6 |
|
Description: Escherichia coli (strain K12) Ferric uptake regulation protein, recombinant protein. |
|||
) Recombinant Escherichia coli hic Protein (aa 20-47) |
|||
| VAng-Lsx02425-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2881.2 |
|
Description: Escherichia coli Lysis protein for colicins E2 and E3, recombinant protein. |
|||
Recombinant Escherichia coli hic Protein (aa 20-47) |
|||
| VAng-Lsx02425-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2056.8 |
|
Description: Escherichia coli Lysis protein for colicins E2 and E3, recombinant protein. |
|||
Recombinant Escherichia coli hic Protein (aa 20-47) |
|||
| VAng-Lsx02425-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1429.2 |
|
Description: Escherichia coli Lysis protein for colicins E2 and E3, recombinant protein. |
|||
) Recombinant Escherichia coli imm Protein (aa 1-113) |
|||
| VAng-Lsx02440-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3508.8 |
|
Description: Escherichia coli Colicin-E1 immunity protein, recombinant protein. |
|||
Recombinant Escherichia coli imm Protein (aa 1-113) |
|||
| VAng-Lsx02440-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2518.8 |
|
Description: Escherichia coli Colicin-E1 immunity protein, recombinant protein. |
|||
Recombinant Escherichia coli imm Protein (aa 1-113) |
|||
| VAng-Lsx02440-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1726.8 |
|
Description: Escherichia coli Colicin-E1 immunity protein, recombinant protein. |
|||
) Recombinant Escherichia coli kch Protein (aa 1-417) |
|||
| VAng-Lsx02449-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli (strain K12) Voltage-gated potassium channel Kch, recombinant protein. |
|||
) Recombinant Escherichia coli lgt Protein (aa 1-291) |
|||
| VAng-Lsx02461-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli O1:K1 / APEC Prolipoprotein diacylglyceryl transferase, recombinant protein. |
|||
) Recombinant Escherichia coli lit Protein (aa 1-297) |
|||
| VAng-Lsx02464-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli (strain K12) Bacteriophage T4 late gene expression-blocking protein, recombinant protein. |
|||
) Recombinant Escherichia coli lnt Protein (aa 1-512) |
|||
| VAng-Lsx02465-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli (strain K12) Apolipoprotein N-acyltransferase, recombinant protein. |
|||
) Recombinant Escherichia coli lys Protein (aa 18-45) |
|||
| VAng-Lsx02477-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 2881.2 |
|
Description: Escherichia coli Lysis protein for colicin E1, recombinant protein. |
|||
Recombinant Escherichia coli lys Protein (aa 18-45) |
|||
| VAng-Lsx02477-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2056.8 |
|
Description: Escherichia coli Lysis protein for colicin E1, recombinant protein. |
|||
Recombinant Escherichia coli lys Protein (aa 18-45) |
|||
| VAng-Lsx02477-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1429.2 |
|
Description: Escherichia coli Lysis protein for colicin E1, recombinant protein. |
|||
) Recombinant Escherichia coli map Protein (aa 2-264) |
|||
| VAng-Lsx02487-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3952.8 |
|
Description: Escherichia coli Methionine aminopeptidase, recombinant protein. |
|||
Recombinant Escherichia coli map Protein (aa 2-264) |
|||
| VAng-Lsx02487-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2535.6 |
|
Description: Escherichia coli Methionine aminopeptidase, recombinant protein. |
|||
Recombinant Escherichia coli map Protein (aa 2-264) |
|||
| VAng-Lsx02487-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 687.6 |
|
Description: Escherichia coli Methionine aminopeptidase, recombinant protein. |
|||
) Recombinant Escherichia coli ppx Protein (aa 2-513) |
|||
| VAng-Lsx02569-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5751.6 |
|
Description: Escherichia coli (strain K12) Exopolyphosphatase, recombinant protein. |
|||
Recombinant Escherichia coli ppx Protein (aa 2-513) |
|||
| VAng-Lsx02569-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3657.6 |
|
Description: Escherichia coli (strain K12) Exopolyphosphatase, recombinant protein. |
|||
Recombinant Escherichia coli ppx Protein (aa 2-513) |
|||
| VAng-Lsx02569-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1083.6 |
|
Description: Escherichia coli (strain K12) Exopolyphosphatase, recombinant protein. |
|||
) Recombinant Escherichia coli pth Protein (aa 1-194) |
|||
| VAng-Lsx02589-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3952.8 |
|
Description: Escherichia coli (strain K12) Peptidyl-tRNA hydrolase, recombinant protein. |
|||
Recombinant Escherichia coli pth Protein (aa 1-194) |
|||
| VAng-Lsx02589-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2535.6 |
|
Description: Escherichia coli (strain K12) Peptidyl-tRNA hydrolase, recombinant protein. |
|||
Recombinant Escherichia coli pth Protein (aa 1-194) |
|||
| VAng-Lsx02589-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 687.6 |
|
Description: Escherichia coli (strain K12) Peptidyl-tRNA hydrolase, recombinant protein. |
|||
) Recombinant Escherichia coli rbn Protein (aa 1-290) |
|||
| VAng-Lsx02593-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli (strain SE11) UPF0761 membrane protein yihY, recombinant protein. |
|||
) Recombinant Escherichia coli rtn Protein (aa 1-518) |
|||
| VAng-Lsx02617-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli (strain K12) Protein Rtn, recombinant protein. |
|||
) Recombinant Escherichia coli trg Protein (aa 1-546) |
|||
| VAng-Lsx02671-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli (strain K12) Methyl-accepting chemotaxis protein III, recombinant protein. |
|||
) Recombinant Escherichia coli wzc Protein (aa 1-720) |
|||
| VAng-Lsx02701-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Escherichia coli (strain K12) Tyrosine-protein kinase wzc, recombinant protein. |
|||
) Recombinant Escherichia coli cea Protein (aa 1-522) |
|||
| VAng-Lsx3110-10g | Creative Biolabs | 10 µg | EUR 4665.6 |
|
Description: Escherichia coli Colicin-E1, recombinant protein. |
|||
